[PDF][PDF] Stanowisko Zespołu Ekspertów dotyczące stosowania cynakalcetu u chorych z hiperkalcemią w przebiegu przetrwałej nadczynności przytarczyc po …

B Rutkowski, M Durlik, M Nowicki… - Forum …, 2014 - ppm-system.gumed.edu.pl
ABsTRAcT a chronic allograft dysfunction. Mineral disorders after kidney transplantation are
mostly characterized by hypercalcemia, increased serum PTH concentration and …

[PDF][PDF] Mineral and Bone Disease (MBD) on a Kidney Transplant Patient

R Birne, T Adragão, A Ferreira, J Dickson… - Portuguese Journal of …, 2014 - bbg01.com
∎ ABSTRACT A 50-year-old post-menopausal recipient of a kidney allograft with bone pain,
osteoporosis, persistent hypercalcaemia and elevated parathormone (PTH) levels, despite a …

The EVOLVE Study: Another Disappointment for Nephrologists?

A Cavalli, G Pontoriero - Giornale di Tecniche Nefrologiche …, 2013 - journals.sagepub.com
The calcimimetic cinacalcet is now being used for years to treat secondary
hyperparathyroidism (SHPT) in dialysis patients, allowing a good reduction in PTH levels. In …

[PDF][PDF] OSTEOLOGICKÝ BULLETIN

R RADA - smos.cz
Obrázek na titulní straně: Pacientka se zlomeninou horního raménka stydké kosti vlevo.
Předozadní snímek obou kyčlí budí podezření subkapitální zlomeniny krčku vlevo. Axiální …

[PDF][PDF] Los calcimiméticos no han tenido impacto en la cirugía del hiperparatiroidismo terciario

I Okonkwo - J Korean Med Sci, 2001 - academia.edu
El hiperparatiroidismo terciario (HPTT) ocurre en un 2-25% de los pacientes trasplantados
renales con función renal normal, debido a la proliferación autónoma de las glándulas …

[引用][C] Parathyroidectomy Before or After Transplantation: A Dilemma Still Open!

G La Manna - Artificial Organs, 2018 - Wiley Online Library
Secondary hyperparathyroidism (SHP) is a nearly constant feature of chronic kidney disease
(CKD). Other than it is well-known effects on the bone, namely fibrous osteitis and mixed …

[引用][C] Troubles hydroélectrolytiques

A Kanfer, O Kourilsky, MN Peraldi - Néphrologie et troubles hydroélectrolytiques …, 2001

[引用][C] ¿ Qué lugar ocupa cinacalcet en la terapéutica del hiperparatiroidismo secundario?

S Viroga, S Fabbiani - … , 2020, vol. 11 …, 2020 - Facultad de Medicina. Hospital de …

[引用][C] Parathyroidectomy Outcomes in Renal Transplant Recipients: Subtotal vs. Total. Arch Transplant 1: 1

R Rathore, K Tomlinson, A Sharma, A Halawa - of, 2017

[引用][C] Chronic kidney disease-mineral and bone disorder with emphasis on vitamin D deficiency, hypercalcemic hyperparathyroidism, and hypercalcitoninemia

PDDK Borchhardt - 2015 - Medical University of Vienna